Andes Biotechnologies participated in the online version of the VIII Latin American Symposium of Oncology Gastroenterology (SLAGO, in Spanish), organized by the foundation Cancer Chile. The event gathered health professionals from Latin America to share and discuss the latest advances in oncology treatments affecting the digestive system and their clinical applicability in the Region.
The focus of the presentation was to update the audience on Andes’ clinical development in its Phase 1b trial for cervical, gastric, pancreatic and bladder cancer cohorts.
